Policy to Reduce Antipsychotic Use and Hospitalization of Nursing Home Residents With Dementia.

Journal of the American Medical Directors Association
Sijiu WangShubing Cai

Abstract

Following the 2012 launch of the National Partnership to Improve Dementia Care in Nursing Homes (the National Partnership), the use of antipsychotics has declined. However, little is known about the impact of this effort on quality of care and outcomes for nursing home (NH) residents with Alzheimer's disease and related dementia (ADRD). The objective of this study is to examine changes in hospitalizations for NH long-stay residents with ADRD after the launch of the National Partnership. Observational cross-sectional study. NH residents who were newly admitted into NHs and became long-stay residents between January 2011 and March 2015 (n = 565,885). We estimated linear probability models to explore the relationship between the National Partnership and the likelihood of NH-originated hospitalizations for NH long-stay residents with ADRD, accounting for facility fixed effect, individual covariates, and concurrent changes in hospitalizations among residents without ADRD. We further stratified the analysis by NHs according to their prevalence of antipsychotic use at baseline (ie, prior to the National Partnership). We detected a 0.7-percentage point relative increase (P value <.01) in risk-adjusted probabilities of hospitalizations ...Continue Reading

References

Feb 1, 1977·Journal of the American Geriatrics Society·A B CovertK Solomon
Jun 1, 1996·Medical Care Research and Review : MCRR·N G Castle, V Mor
Jan 5, 2000·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·J N MorrisS A Morris
Jul 24, 2004·Journal of the American Geriatrics Society·Kaycee M SinkKristine Yaffe
Jan 7, 2005·American Journal of Alzheimer's Disease and Other Dementias·Myra A Aud
Jun 16, 2005·Archives of Internal Medicine·Becky A BriesacherBruce Stuart
Jan 30, 2008·Clinical Interventions in Aging·Elizabeth C Hersch, Sharon Falzgraf
May 28, 2008·Archives of Internal Medicine·Paula A RochonJerry H Gurwitz
Dec 20, 2008·Journal of the American Geriatrics Society·Christopher M Perlman, John P Hirdes
Sep 8, 2010·Health Affairs·Rachel WernerDaniel Polsky
Dec 17, 2010·Journal of the American Geriatrics Society·Russ S Muramatsu, Deborah Goebert
Nov 22, 2012·JAMA : the Journal of the American Medical Association·Laura N GitlinConstantine G Lyketsos
Feb 7, 2013·JAMA : the Journal of the American Medical Association·Becky A BriesacherJerry H Gurwitz
Mar 13, 2014·Journal of the American Geriatrics Society·R Tamara KonetzkaRachel M Werner
Jan 21, 2015·Health Services Research·John R BowblisChristopher S Brunt
Mar 13, 2015·Medical Care·Kali S ThomasVincent Mor
Jun 16, 2017·JAMA : the Journal of the American Medical Association·Jerry H GurwitzDonald M Berwick
Nov 10, 2018·Journal of the American Medical Directors Association·Xi CenHelena Temkin-Greener
May 3, 2019·Journal of the American Medical Directors Association·Helena Temkin-GreenerYue Li

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here